This study assessing the efficacy and safety of Ozurdex implant alone Vs Ozurdex implant plus Laser in patient with impairment of vision due to ophthalmic illness (Macular Edema follow by Branch Retinal Vein Occlusion).
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Branch Retinal Vein Occlusion (BRVO)
- Registration Number
- CTRI/2014/03/004508
- Lead Sponsor
- Allergan India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1.Fluorescein proven perfused macular edema involving the foveal center
2.Vision reduced to <6/12
3.On OCT macular thickness greater than 250 micron
4. BRVO less than 90 days
5.Willing to give informed consent
Exclusion Criteria
1.Media opacities which can interfere with the investigative modalities ad visualization
2.Uncontrolled/advanced glaucoma
3.Active/suspected viral infections of eye
4.Diabetic retinopathy
5.Patient unwilling to give consent
6.One eyed patient
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method